Annovis Bio, Inc. (ANVS) Shareholders’ equity 2019–2025
Annovis Bio, Inc. (ANVS) shareholders’ equity at each fiscal year-end, per SEC filings.
$16.9MFY2025 · since FY2019: -$8.6M → $16.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.9M | +81.0% |
| FY2024 | $9.3M | +220.1% |
| FY2023 | -$7.8M | -127.4% |
| FY2022 | $28.3M | -36.3% |
| FY2021 | $44.5M | +490.0% |
| FY2020 | $7.5M | +187.9% |
| FY2019 | -$8.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice